Newlink Genetics reported $111K in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Agenus AGEN:US $ 25.94M 5.68M
Bristol Myers Squibb BMY:US $ 11648M 337M
Capricor Therapeutics CAPR:US $ 0M 0M
Celldex Therapeutics CLDX:US $ 0.17M 0.16M
Eli Lilly And LLY:US $ 7810M 189.9M
Intrexon XON:US $ 32.02M 7.8M
Merk MRK:US $ 15901M 2380M
Nektar Therapeutics NKTR:US $ 24.82M 0.19M
Newlink Genetics NLNK:US $ 0.11M 0.11M
Pfizer PFE:US $ 25661M 2026M
Prothena PRTA:US 1.15M 19K
Sarepta Therapeutics SRPT:US $ 210.83M 9.37M
Vascular Biogenics VBLT:US 113K 83K
YTE INCY:US $ 733.24M 129.62M